Ten years ago the word probiotics wasn’t known, and five years ago it was a new word to most Americans. But thanks to the marketing of Activia yogurt by Dannon, which started in 2006, these microorganisms have garnered national attention.
The latest vindicator to the almost $3.5 billion vitamin and supplement business across all outlets isn’t positive press. It’s not even the continued consumer gravitation toward self-care. It’s Wall Street.
Walgreens has teamed with Greater Than AIDS, a national campaign in response to HIV/AIDS in the United States, to distribute informational resources and specialized HIV-related services at more than 300 Walgreens pharmacies in heavily affected communities, the Kaiser Family Foundation announced Tuesday.
Schiff Nutrition president and CEO Tarang Amin promised to infuse some new energy into the company with his appointment earlier this spring, and he wasted no time with the Schiff acquisition of two probiotic brands — Sustenex and Digestive Advantage — in June.
Many adults across the United States opted to visit their local drug store or supermarket to receive their flu shot during the 2010-2011 influenza season, according to the Centers for Disease Control and Prevention's "Morbidity and Mortality Weekly Report."
The vaccines division of drug maker Sanofi donated vaccine doses on behalf of the Jeff Gordon Children's Foundation to Direct Relief International, which will aid victims of the recent storms in the Southeast and Midwest.
The Centers for Disease Control and Prevention said that the Food and Drug Administration has recommended that the flu vaccine for the 2011-2012 season protect against the same strains as it did this year.
Schiff Nutrition on Tuesday announced its $40 million acquisition from Ganeden Biotech of the worldwide exclusive rights to use the probiotic technology GanedenBC30 in the over-the-counter and dietary supplement space, along with the brands Sustenex and Digestive Advantage, under which GanedenBC30 currently is sold.
Patients with HIV who immediately started antiretroviral therapy significantly reduced the risk of spreading the virus to an uninfected partner, compared with those who delayed therapy, according to results of a multinational study. The study also found that antiretroviral therapy reduced the risk of transmission by 96%.
Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.
Napo Pharmaceuticals has filed a lawsuit against Salix Pharmaceuticals, alleging that the latter breached commitments under an agreement to develop and commercialize a proprietary gastrointestinal compound.